Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CardiAMP autologous cell therapy in ischemic heart failure
NCT02438306Phase 3Completed
- Sponsor
- BioCardia, Inc.
- Start
- Dec 2016
- Primary completion
- Feb 2025
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 3 trial of autologous bone marrow-derived mononuclear cell in Ischemic Heart Failure (IHF), sponsored by BioCardia, Inc.. Started Dec 2016; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
Ischemic Heart Failure (IHF)
Beyond the preview
Go deeper on NCT02438306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02438306.